TPST
TPST
NASDAQ · Biotechnology

Tempest Therapeutics Inc

$1.73
+0.07 (+4.22%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +2,427.2% upside
Low Target $35.70
Average Target $43.72
High Target $58.20
Current Price $1.73
Current
$1.73
Target
$43.72
$35.70 $43.72 avg $58.20
Scenario Analysis
Bear Case
$35.70
1,963.6%
Low target
Base Case
$43.72
+2,427.2%
Avg target
Bull Case
$58.20
+3,264.2%
High target
Risk/Reward
1.7x
Balanced
Price in Context
52-Week High
$12.23
-85.9% from high
52-Week Low
$1.65
+5.2% from low
Target vs 52W High
$43.72
+257.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +18.4%
AMGN
Amgen Inc
Hold 42 50% $190.87 -45.8%
GILD
Gilead Sciences Inc
Strong Buy 38 79% $362.68 +160.2%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -1.8%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.1%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -69.1%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -12.3%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -28.5%